All 33 CVE vulnerabilities found in MedDream PACS Premium, with AI-generated Chinese analysis, references, and POCs.
This page documents known security weaknesses affecting MedDream PACS Premium, a medical imaging software product developed by Nulibis. It aggregates verified vulnerability data associated with this specific platform, focusing on flaws that could potentially compromise the integrity, confidentiality, or availability of patient data and system operations. The collection includes various common weakness types such as insecure configurations, potential cross-site scripting issues, and information disclosure flaws that have been identified by security researchers, independent auditors, or disclosed by the vendor itself. The data covers vulnerabilities discovered and reported from January 2020 through the present, providing a comprehensive historical view of the product's security landscape during this period. By reviewing this aggregated information, users can track vendor advisories and patch release timelines to ensure their deployment remains secure against known threats. Analysts and security teams can use this resource to understand the prevalence and nature of specific weakness classes within the context of this particular PACS solution. Additionally, IT administrators can look up the product's vulnerability history to assess risk exposure, prioritize remediation efforts, and verify whether critical patches have been applied. This centralized view helps streamline the process of maintaining compliance with healthcare data security standards, such as HIPAA, by providing a clear record of identified issues and their resolution status. The information is presented in a neutral, factual manner to support informed decision-making without exaggeration or promotional language, ensuring that stakeholders have access to accurate and actionable security intelligence.
Vendor: MedDream
All 33 known CVE vulnerabilities affecting MedDream PACS Premium with full Chinese analysis, references, and POCs where available.